Spectrum of Disease and Prescription Pattern for Outpatients with Neurological Disorders: An Empirical Pilot Study in Bangladesh

Abstract

Background: Neurological disorders represent one of the most prominent causes of morbidity and mortality that adversely affect the lifestyle of patients and a major percentage of these diseases exists in developing countries. Purpose: The objective of this study was to examine the prevalence and prescription pattern for outpatients with neurological disorders in Bangladesh. Methods: The study was conducted on 1,684 patients in 6 hospitals (National Institute of Neurosciences and Hospital, Dhaka Medical College and Hospital, Bangabandhu Sheikh Mujib Medical University, Shaheed Suhrawardy Medical College, Sir Salimullah Medical College, and Apollo Hospitals Dhaka) of the Dhaka City from March 2014 to June 2015. Data were collected through a predesigned questionnaire from the patients that contain information about gender, age, marital status, occupation, residential status, affected disease, self-medicated medicines, and prescribed medicines. Results: Out of 1,684 patients, 28.38% patients were aged 51–60 years and male, 57.19% predominance. The study exposed headache and migraine for 29.75% patients, followed by stroke for 23.93% patients and seizure for 7.07% patients. Genetic reason for the neurological disorders was seen only among 12.35% patients. In this study, 16.98% patients had been affected by neurological disorders for more than 2 years and 19% of patients for less than 6 months. Most extensively prescribed medicines were multivitamins and multiminerals used by 17.89% of patients followed by nonsteroidal anti-inflammatory drugs and other analgesic by 14.84%; afterwards antiulcerants were used by 12.62%, subsequently anticoagulants were used by 11.61% followed by antihyperlipidemic medicines by 10.26% and antiepileptic drugs by 8.08% of patients. The crucial reasons for the selection of prescribed medicines were the confidence that patients had with the physician’s prescribed medicines, which was shown for 40.97% patients and knowledge of the medicines was reported for 35.04% patients. The period of prescribed medicine usage was 1–3 months for 39.73% patients and 3–6 months for 29.16% patients. The patient’s compliance for prescribed medicines was satisfactory for 34.56% patients, good for 28.15% patients, and side effects were reported for 23.22% patients. Conclusion: In Bangladesh, it is not surprising to note that neurological diseases are more prevalent than other different diseases among different age groups and genders. Headache and migraine, stroke and seizure are most frequently encountered neurological disorders here. Treatment procedure of these disorders is not quite suitable due to the anomalies of health care management systems. Appropriate management of the health care system, especially the placement of hospital and community pharmacy can overcome the existing inconsistencies as well as increase the knowledge, awareness, and perception of the patients about health and neurological disorders.

Spectrum of neurological disorders in neurology outpatients clinics in urban and rural Sindh, Pakistan: a cross sectional study

“…The first three prevalent disorders for both urban and rural areas are stroke, headache disorders and nerve and root lesions disorders. Almost similar trend was reported in previous studies [20, 24, 25]. A study from Karachi shows that the leading diagnoses were stroke 98.2%, Parkinson’s 67.7% and depression 77.5% [13].…”

Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease

“…The harmful activities of free radicals and oxidized metabolites in AD include DNA oxidation, lipid peroxidation, and protein oxidation, which ultimately leads to neuronal death [5][6][7][8]. Significant advancement has been achieved to understand AD pathogenesis, since currently available therapeutic methods only deliver moderate relief of cognitive symptoms, such as impairments in perception and memory [9][10][11]. Although, for drug developers, AD has proven to be tremendously challenging, researchers continue to discover better anti-Alzheimer's treatments.…”

Analyzing the chance of developing dementia among geriatric people: a cross‐sectional pilot study in Bangladesh

“…Furthermore, dementia caused around 46 million deaths in 2015, whereas this figure was only 0.8 million in 1990 . The rates of dementia rise markedly with ageing; it affects 5% of people older than 65 years but 20–40% of those older than 85 years . Dementia is the third most common cause of death in the UK.…”